Financials
| Half-year Report | May. 20, 2025 |
| Trading Update | Apr. 16, 2025 |
| Financial Results for year ended 30 September 2024 | Dec. 04, 2024 |
| Trading Update | Aug. 14, 2024 |
| Half-year Report | May. 21, 2024 |
| Trading Update | Mar. 13, 2024 |
| Financial Results for year ended 30 September 2023 | Dec. 05, 2023 |
Proxies
| Result of AGM | Jan. 24, 2025 |
| Result of AGM | Jan. 25, 2024 |
| Result of AGM | Jan. 27, 2023 |
| Result of AGM | Jan. 20, 2022 |
| Result of AGM | Jan. 21, 2021 |
| Result of AGM | Jan. 18, 2019 |
| Result of AGM | Jan. 22, 2018 |
Ownership Update
| Share option awards and PDMR Dealing | Jun. 13, 2025 |
| Holding(s) in Company | May. 20, 2025 |
| Holding(s) in Company | May. 08, 2025 |
| Issue of share options and PDMR dealing | Feb. 07, 2025 |
| Share Option Award & PDMR Dealings | Dec. 04, 2024 |
| Share Option Awards & PDMR Dealing | Oct. 31, 2024 |
| Holding(s) in Company | Oct. 30, 2024 |
Announcements
| FDA Clearance of Alzheimer's Diagnostic Biomarker | Jun. 10, 2025 |
| Notice of Interim Results & Investor Presentation | May. 06, 2025 |
| Contract Win | Feb. 27, 2025 |
| Further Validation of IXICO’s AI Imaging Platform | Feb. 12, 2025 |
| Contract Win | Dec. 10, 2024 |
| Notice of Results and Investor Presentation | Nov. 25, 2024 |
| Result of GM, Issue of Equity & TVR | Oct. 25, 2024 |